PROFESSIONAL EDITION

The largest community of pharma leaders

Regulatory Affairs

Merck Announces U.S. FDA Approval of VERQUVO® (vericiguat)

KENILWORTH, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck Announces U.S. FDA Approval of VERQUVO® (vericiguat) Source Business Wire Health: Pharmaceutical NewsRead More

Applied DNA Promotes Judith Murrah to Chief Operating Officer

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #COVID19--Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced...

Biologics License Application for Narsoplimab in HSCT-TMA Accepted for Priority Review by U.S. FDA

SEATTLE--(BUSINESS WIRE)--Omeros Corporation (Nasdaq: OMER) announced today that the Biologics License Application (BLA) for narsoplimab for the treatment of hematopoietic stem cell transplant-associated thrombotic...

Recent Articles